top of page
flowsaber_httpss.mj.runTh0udxSHeAE_httpss.mj.runhp6iBSe9rAc_htt_1a859bb6-6d2e-4bb2-9857-01

Technology

exhausted hero nice 2.jpg

The Problem

Patients frequently present with common, seemingly minor, symptoms such as fatigue or shortness of breath that are actually warning signs of a serious underlying chronic disease. It can currently take up to four years to diagnose these serious conditions which delays the physician from developing a treatment plan and subjects the patient to reduced quality of life and increased risk of mortality. 

Patients frequently present with common, seemingly minor, symptoms such as fatigue or shortness of breath that are actually warning signs of a serious underlying chronic disease. It can currently take up to four years to diagnose these serious conditions which delays the physician from developing a treatment plan and subjects the patient to reduced quality of life and increased risk of mortality. 

The Problem

exhausted hero nice 2.jpg
best metfora vials (single vial) single vial only.jpg

The Solution

At Metfora, we have developed a minimally invasive blood test that quickly analyzes metabolites in blood to determine what diseases are present. For patients and physicians, this means a potential diagnosis in as little as three days and allows for early intervention and treatment. Not only can our test serve symptomatic patients, but it also has utility in monitoring and screening patients through routine checkups with their primary care physician.

At Metfora, we have developed a minimally invasive blood test that quickly analyzes metabolites in blood to determine what diseases are present. For patients and physicians, this means a potential diagnosis in as little as three days and allows for early intervention and treatment. Not only can our test serve symptomatic patients, but it also has utility in monitoring and screening patients through routine checkups with their primary care physician.

best metfora vials (single vial) single vial only.jpg

The Solution

flowsaber_a_busy_modern_healthcare_facility_depth_of_field_cris_e4d0e89c-ce04-4532-9caa-d3

Benefits for Healthcare System

Metfora’s rapid test benefits healthcare systems as a faster time to diagnosis reduces overall healthcare expenditure, facilitating strategic resource allocation allowing focus on highest demands.

og doctor final.jpg

Benefits for Physicians

Physicians are empowered with valuable disease-state information earlier than ever before, allowing them to provide therapeutic intervention at earlier stages of disease. Additionally, our diagnostic test is perfect for monitoring the effectiveness of the patient’s treatment plan, so that plan adjustments are made in real-time if treatments are sub-optimal.

flowsaber_cinematic_shot_of_an_elderly_indian_woman_exercising__2bd10eb5-d575-48df-ac26-f0

Benefits for Patitents

We optimize patient treatment within the therapeutic window through an accelerated time to diagnosis, via a minimally invasive blood draw. Patients will be able to access our test through both primary care physicians as well as specialists.

Publications

January 14, 2020

Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites

September 26, 2019

Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development

March 3, 2016

Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung

bottom of page